An animal vaccine composition and method effective in preventing or ameliorating avian influenza virus (“bird flu”) infection is provided. The vaccine contains at least two inactivated viral strains with a combined hemagglutinin total of at least 200 HA/dose.
bird flu, vaccine, H5N1, H5N3
Granted Patents or Published Applications
Pending U.S. application published May 22, 2008 as US 2008/0118531 and international application published Nov. 1, 2007 as WO/2007/124479
Related Scientific References
Webster, R.G. et al., “The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens”, Virology 351(2): 303-311 (2006).
We are currently seeking nonexclusive licensing opportunities in all fields for the development of this technology. These patent rights are co-owned with Fort Dodge Animal Health, a division of Wyeth.
Contact the Office of Technology Licensing (Phone: 901-595-2342, Fax: 901-595-3148) for more information.